Prescription drug · ANDA
Questran (Cholestyramine) NDC 49884-937
Cholestyramine 4 g/5g · Powder, For suspension · Oral · Par Health USA, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 49884-937-67 | 4988409376749884093767 | 210 g in 1 CAN (49884-937-67)Marketed from Jul 24, 2003 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Questran
- Generic name (nonproprietary)
- cholestyramine
- Active ingredients
- Cholestyramine — 4 g/5g
- Dosage form
- Powder, For suspension
- Route
- Oral
- Labeler
- Par Health USA, LLCNDC labeler code 49884
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 077203
- Marketing start
- Listing expires
- Other FDA classes
- Bile-acid Binding Activity (Mechanism)
- Identifiers
- Product ID 49884-937_55dc80b2-b583-45b9-9c28-708231ea5b5cSPL ID 55dc80b2-b583-45b9-9c28-708231ea5b5cSPL set ID 362ddd91-a63f-4ec6-841a-75785dd208c8RxCUI 848943, 848949, 1801279, 1801280UNII 4B33BGI082
- Pharmacologic class
- Bile Acid Sequestrant
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N449884093767followed by a unit qualifier and the quantityPackage 49884-0937-67. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE 1) QUESTRAN (Cholestyramine for Oral Suspension USP), is indicated as adjunctive therapy to diet for the reduction of elevated serum cholesterol in patients with primary hypercholesterolemia (elevated low density lipoprotein [LDL] cholesterol) who do not respond adequately to diet. QUESTRAN may be useful to lower LDL cholesterol in patients who also have hypertriglyceridemia, but it is not indicated where hypertriglyceridemia is the abnormality of most concern. Therapy with lipid-altering agents should be a component of multiple risk factor intervention in those individuals at significantly increased risk for atherosclerotic vascular disease due to hypercholesterolemia.…
Excerpt only. Read the full label for complete information.
About NDC 49884-937
- What is NDC 49884-937?
- 49884-937 is the product NDC for Questran (cholestyramine), Cholestyramine 4 g/5g powder, for suspension, listed with the FDA by Par Health USA, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Questran (Cholestyramine).
- What is the active ingredient?
- Cholestyramine.
- Who is the labeler?
- Par Health USA, LLC, NDC labeler code 49884. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Questran?
- 1 other product NDC are listed under this name. See all Questran NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Questran products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Questrancholestyramine | Cholestyramine 4 g/9g | Powder, For suspensionOral | Par Health USA, LLC | 49884-936 | 49884-0936-6549884-0936-66 |
Other NDCs under ANDA 077203
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Cholestyramine | Cholestyramine 4 g/5g | Powder, For suspensionOral | Par Health USA, LLC | 49884-466 |
| Cholestyramine | Cholestyramine 4 g/5g | Powder, For suspensionOral | Bryant Ranch Prepack | 63629-2162 |
| Cholestyramine | Cholestyramine 4 g/5g | Powder, For suspensionOral | Bryant Ranch Prepack | 72162-1505 |